SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

ISSN
2211-1247
Date Issued
2021
Author(s)
Hoffmann, Markus
Hofmann-Winkler, Heike
Krüger, Nadine
Kempf, Amy
Nehlmeier, Inga
Graichen, Luise
Arora, Prerna
Sidarovich, Anzhalika
Moldenhauer, Anna-Sophie
Winkler, Martin S.
DOI
10.1016/j.celrep.2021.109415